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Abstract
Background: The purpose of this paper is to study the spatial agreement between visual field defects and ultra-wide
field (UWF) fundus autofluorescence (FAF) in patients with birdshot chorioretinopathy (BSCR). The study is a retrospective,
cross-sectional analysis of a university uveitis practice. Eight (8) eyes of five (5) patients with BSCR were included. Inclusion
criteria were ability to fixate reliably. Goldmann visual fields (GVF) and UWF FAF were obtained, digitalized, and
standardized. Analysis was performed by measuring areas of overlap of hypo-autofluorescent FAF lesions and GVF
scotomas within the central 60°. Overlap was calculated as a percentage of the total area of FAF and GVF, respectively.
Average areas were also calculated.
Results: The mean age of the subjects was 51 ± 12.28 years (range 38–69 years). 14 ± 23 % of the total lesion area
identified as hypo-autofluorescent on FAF overlapped with scotoma. 28 ± 41 % of the GVF scotomas overlapped with
hypo-autofluorescent FAF lesions. Average area of FAF hypo-autofluorescence was much larger (15.19 disc areas) than
GVF (3.45 disc areas).
Conclusions: There appear to be larger total areas of hypo-autofluorescence on FAF than scotoma evidenced by GVF
and only a small amount of overlap. The finding suggests that GVF is relatively insensitive to anatomic loss, which can
be detected using FAF. Further studies are required to assess whether this finding holds true for automated
white-on-white perimetry. In addition, more selective psychophysical stimuli may have higher sensitivity in
detecting early functional loss that accompanies anatomic damage.
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Background
Birdshot chorioretinopathy (BSCR) is a form of inflam-
matory posterior uveitis characterized by typical clinical
and imaging characteristics. This condition is associated
with bilateral hypo-pigmented chorioretinal “birdshot”
lesions affecting the peripapillary and posterior region
[1–3]. Excellent visualization of these lesions is possible
using ultra-wide field (UWF) imaging techniques of fun-
dus photography and fundus autofluorescence (FAF)
compared to conventional imaging [4, 5]. However, the
lack of correspondence between the various imaging
techniques has been well recognized in BSCR. Therefore,
the clinicians often rely on a number of imaging and
diagnostic tests in order to characterize the disease
entity [3, 6].
BSCR appears to have a chronic, progressive course
with most patients developing functional loss over a
long-term follow-up [7]. Visual acuity appears to be a
poor indicator of disease activity, necessitating ancillary
tests such as electrophysiology and visual field testing
[7–9]. Goldmann visual field (GVF) testing is a more
widely available tool for evaluation of visual function
compared to electroretinogram (ERG), which may be
more expensive and time-consuming [10]. While a
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number of ophthalmology practices have moved from
GVF to automated visual field testing for longitudinal
follow-up of patients with BSCR, GVF remains an im-
portant testing modality [11, 12]. Previous reports sug-
gest that serial, quantitative GVF testing in patients with
BSCR may allow detection of change in retinal function
following therapeutic interventions [10].
Evaluation of spatial agreement between UWF FAF and
GVF has been performed in other retinal pathologies,
such as retinitis pigmentosa [13]. However, the relation-
ship between visual function changes on GVF (i.e., scot-
omas defined by the V4e isopter, as well as other changes
such as generalized constriction of the visual field) and
autofluorescence patterns on UWF FAF in BSCR has not
been established. In the index study, we analyzed the
agreement between the hypo-autofluorescent areas on
UWF FAF and GVF scotomas in patients with BSCR.
Methods
The study was conducted at the retina and uveitis services
of the Stanley M. Truhlsen Eye Institute, University of
Nebraska Medical Center. Institutional Review Board (IRB)
clearance was obtained and the study adhered to the tenets
of the Declaration of Helsinki. All the study procedures
were compliant as per the HIPAA act of 1996. This retro-
spective, observational case series included patients diag-
nosed with BSCR from January 2013 to December 2014.
The diagnosis was established based on clinical findings,
slit-lamp biomicroscopy, and indirect ophthalmoscopic
visualization of characteristic yellow-orange ovoid chorior-
etinal lesions with mild vitritis, as per the International
Consensus Conference on BSCR [14]. Best-corrected visual
acuity (BCVA) was obtained. Serologic testing of infectious
etiologies and human leucocyte antigen (HLA)-A29 testing
was performed as indicated. Demographic details and
treatment regimens for each patient was noted.
Imaging protocol
All the patients underwent imaging studies including
UWF color fundus photography, fluorescein angiography
(FA), and FAF (Optos P200Tx, Optos Inc., Scotland,
UK). Sixteen eyes of 8 patients were screened for inclu-
sion in the study. The exclusion criteria were unreliable
GVF testing, poor central fixation due to central visual
loss and media opacity precluding adequate imaging.
GVF testing was performed using Haag-Streit system,
Bern, Switzerland, using V4e, I4e, I2e, and I1e test
targets. A single, trained operator tested the visual fields
to minimize the variability of the tests. Scotoma was
defined using the V4e isopter.
Overlap analysis
The GVF test results were scanned and digitalized using
Adobe Photoshop Elements 11.0 (Adobe Inc., San Jose,
CA, USA). ImageJ software (National Institutes of Health,
NIH, Bethesda, MD, USA) [15] was used to quantify the
area of each defect on the digital GVF images in the cen-
tral 60°. Hypo-autofluorescent areas on the UWF FAF and
the scotomas on the GVF were measured in terms of disc
diameters using ImageJ software. The area of overlap was
determined by aligning the point of central fixation of the
GVF with the center of the fovea on FAF and superimpos-
ing the physiologic blind spot with the optic nerve. The
FAF images were vertically flipped so that these images
could be superimposed to the digitalized GVF printouts.
The area consisting of the physiologic blind spot on GVF
and area of the optic nerve on FAF were excluded from the
analysis in order to selectively study pathologic changes de-
tected on imaging. The overlap analysis was performed by
two independent graders.
Statistical analysis
The data analysis was performed using GraphPad Prism
6 (GraphPad Inc., La Jolla, CA, USA). The area of scot-
omas on V4e isopter was calculated in terms of disc
areas on both GVF and FAF. The percentage area of
hypo-autofluorescence on FAF that overlapped with the
scotomas on GVF was calculated. Similarly, the percent-
age area of the scotoma that overlapped with the FAF was
calculated. Bland-Altman analysis was used to evaluate
the agreement between the two techniques in detecting
the areas involved by the disease process. Inter-observer
agreement for the measured values was calculated using
the intraclass correlation coefficient (ICC) test. A p value
of <0.5 was considered to be statistically significant.
Results
Data was collected from a total of 16 eyes from 8 pa-
tients. Eight eyes from 5 patients were excluded due to
ungradable image quality, lack of patient cooperation, poor
central fixation, and/or unreliable GVF testing. Eight (8)
eyes of 5 patients (2 males) met the inclusion criteria and
their clinical data and images were included in the analysis.
All the patients included in the study were positive for
HLA-A29. The mean age of all 8 subjects was 51 ±
12.28 years (range 38–69 years). The mean best-corrected
visual acuity for the included eyes (converted to LogMAR
units) measured 0.65 ± 0.39 units. The baseline demo-
graphic details of all the patients are listed in Table 1.
Of the area covered by hypo-autofluorescent lesions
identified on UWF FAF, 14 % (±23 %) overlapped with
scotoma on GVF. On the other hand, 28 % (±41 %) of
the area of GVF scotomas overlapped with the hypo-
autofluorescent lesions seen on UWF FAF. An example
of the overlap analysis is shown in Fig. 1. Average area
of UWF FAF hypo-autofluorescence was 15.19 disc areas
and 3.45 disc areas on GVF. Figure 2 is a graphic repre-
sentation of the overlapping areas between FAF and
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GVF. The ICC for measurement of hypo-autofluorescent
areas on FAF was 0.998; for measurement of GVF was
0.996; and for measurement of the area of overlap was
0.977. The Bland-Altman analysis for the agreement
between the two techniques is shown in Fig. 3. The
Bland-Altman plot demonstrates the poor agreement
between FAF and GVF. In addition, it demonstrates a
negative trend: greater mean of GVF and FAF were asso-
ciated with a more negative GVF minus FAF. Thus, in
eyes with more advanced disease, area of hypofluores-
cence on FAF may exceed GVF loss by a significantly
greater extent (Spearman’s Rho = −0.952 for GVF-FAF
versus mean GVF and FAF; p = 0.0002).
Two distinct patterns of distribution of the hypo-
autofluorescent lesions were noted on FAF imaging. The
majority of eyes (5 out of 8; 62.5 %) demonstrated macular
and extra-macular areas of hypo-autofluorescence. Placoid
hypo-autofluorescence involving the macula was noted in
one eye. The remaining eyes showed peripapillary areas of
hypo-autofluorescence. Unlike the FAF, no consistent pat-
tern of visual field defects was noted on GVF.
Discussion
BSCR is an uncommon form of posterior uveitis with
protean clinical manifestations, often leading to difficulty
in diagnosis [3, 16]. The lesions of BSCR may mimic
other white dot syndromes, making ancillary imaging
tests crucial for the diagnosis and follow-up of patients
[17]. Techniques such as spectral-domain optical coher-
ence tomography [18, 19], FA [6], electrophysiology [20],
and indocyanine green angiography [21] provide valu-
able information regarding the structural and functional
damage in eyes with BSCR. Wide spectrum of patterns
noted on FAF in patients with BSCR helps in the identi-
fication of retinal pigment epithelium (RPE) atrophy.
Lesions of BSCR may be better appreciated on FAF as
compared to clinical fundus photography [17, 22, 23].
Placoid hypo-autofluorescence at the macula in eyes
with BSCR has been shown to correlate significantly
with poor visual outcome [22].
UWF FAF imaging using Optos scanning laser oph-
thalmoscopy system provides a non-invasive technique
to obtain panoramic, high-quality images in a short span
of time [4, 24]. The Optos system uses a wavelength of
532 nm for excitation and detects autofluorescence at
540–800 nm. FAF images obtained using UWF system











1 Female 53 + OS 20/50 4
2 Male 83 + OD 20/50 5
OS 20/50 5
3 Female 63 + OD 20/400 10
4 Female 67 + OD 20/200 11
OS 20/200 11
5 Male 62 + OD 20/60 18
OS 20/30 18
Fig. 1 An example of the overlap analysis performed in the study. a Fundus autofluorescence (FAF) of the right eye demonstrating hypo-autofluorescent
lesions (vertically flipped). b Digitized copy of the Goldmann visual field (GVF) cropped to central 60° demonstrating paracentral scotoma. c Area of hypo-
autofluorescence extracted from the FAF using the red channel. d Area of scotoma extracted from the digitized GVF using the blue channel. e Overlay of
c and d showing no overlap between the red and the blue channels
Jack et al. Journal of Ophthalmic Inflammation and Infection  (2016) 6:18 Page 3 of 7
Fig. 2 Bar graphs for each eye included in the study showing the area (in disc diameters) of (1) abnormal Goldmann visual field (GVF) and normal
fundus autofluorescence (FAF), (2) abnormal FAF and normal GVF, and (3) abnormal GVF and FAF (areas of overlap). The graph shows that there is a
relatively small area of overlap between abnormal GVF and FAF and greater extent of FAF loss
Fig. 3 Bland-Altman plot representing the study eyes (red circles) showing the mean area of Goldman visual field (GVF) and fundus autofluorescence
(FAF) versus the difference (GVF-FAF). The plot demonstrates the individual variation in agreement. The mean difference between GVF and FAF is
negative, indicating a greater extent of the area of FAF defects compared to scotomas on GVF
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may provide important information in the assessment
and follow-up of patients with BSCR as a wider field of
view is obtained [5, 24]. The hypo-autofluorescence on
FAF correlates well with the duration of the disease and
the degree of inflammation in the affected eye [5].
Visual field loss is common among patients with BSCR.
In a previous study by Thorne et al., 75 % of patients had
abnormal field scores for the I4 isopter on GVF [10].
Quantitative improvement in vision-related function has
been documented using GVF in BSCR following systemic
immunosuppressive therapy. In these studies, modified
diabetic retinopathy study (DRS) visual field scores were
obtained using GVF by calculating the sum of degrees
seen along each 30° meridian using I4e and IV41 objects.
Using the above method of calculation, a gain of >20° in
the visual field was found to occur with immunomodula-
tory therapy in patients with BSCR [10, 25]. Thus, GVF
testing appears to be an efficient objective measure for as-
sessment of vision-related functional loss in patients with
BSCR. However, while GVF has been used extensively to
study the functional deficit among patients with BSCR, it
is important to note that in the present day, automated
perimetry may be more commonly employed in the man-
agement of BSCR compared to GVF, which may be more
tedious, more challenging, and time-consuming to per-
form repetitively [11, 12].
In the index study, the typical patterns noted on FAF in-
cluded peripapillary hypo-autofluorescence and scattered
macular and extra-macular areas of hypo-autofluorescence,
which is consistent with what is reported in literature [4, 5,
15, 21]. Comparison of this structural loss of the photo-
receptor/RPE complex using FAF with functional loss using
GVF may provide valuable insights into the disease patho-
physiology and progression. Using overlap analysis, there
appears to be larger total areas of hypo-autofluorescence
on FAF than scotoma evident by GVF (15.19 versus 3.45
disc areas). In addition, less than a third of the abnormal
area identified by FAF and GVF overlapped. There was a
greater percentage of overlap of GVF compared to FAF
(28 versus 14 %, despite compensating for the larger
areas of hypo-autofluorescence on FAF imaging).
One of the reasons for the differences in the findings
of FAF and GVF may be because changes in FAF may
precede functional loss detected by GVF. Thus, detection
of hypo-autofluorescence on FAF may help the clinician
in predicting the areas of the retina that may develop
loss of function in the future. Such concept is consistent
with the observation that significant structural loss at
the level of photoreceptors/RPE may be required before
functional loss can occur. Our study results may also
be partially explained from those observed in glaucoma.
Although BSCR and glaucoma are different diseases
with very dissimilar pathophysiological mechanisms,
the process of visual loss may share certain similarities.
In both the conditions, there is slowly progressive vis-
ual field loss and involvement of retinal photoreceptors,
retinal nerve fiber layer, and the ganglion cells. In stud-
ies performed among glaucoma subjects, GVF testing
has been shown to be insensitive to early visual field
loss with 75 % subjects showing evidence of visual field
defects on automated perimetry 1 year before appearing
on manual GVF testing [26]. Similarly, Quigley et al.
demonstrated that structural damage involving ganglion
cells precedes changes on both manual GVF as well as
automated perimetry but more so on GVF testing [27].
Thus, from the studies that have been reported, it can be
inferred that GVF appears to be an insensitive tool to
detect early structural loss. In addition, psychophysical
evidence from glaucoma studies have shown that size III
white supra-threshold target of white-on-white perimetry
(used in both GVF and automated perimetry, including
the index study) is insensitive to early field loss in glau-
coma. Other testing strategies such as blue-on-yellow per-
imetry (short-wavelength automated perimetry), frequency
doubling technology (FDT), and motion detection tech-
niques have shown to be superior to white-on-white
perimetry for early visual loss detection [28]. Similar find-
ings may occur among patients with BSCR, since ganglion
cell death among patients with early BSCR may be non-
selective just like in glaucoma. Thus, as per the hypothesis
of reduced redundancy [28], sparsely represented ganglion
cell sub-populations have lower degrees of overlap be-
tween adjacent receptive fields than more abundant
sub-populations, and may demonstrate identifiable func-
tional loss earlier. According to such hypothesis, we would
encourage other clinician scientists to investigate BSCR
patients with selective tests of visual function in order to
confirm or refute the above hypothesis.
Parallels can be drawn from glaucoma studies to fur-
ther explain the poor structure-function (FAF-GVF) cor-
relation observed in our study. Evidence suggests that
comparing the available imaging and diagnostic tech-
niques may be associated with a number of confounding
factors that may limit our understanding of structure-
function correlation [29]. Test-retest variability in vis-
ual field testing may be a major source of imprecision
in determining the structure-function relationship.
There may be anatomical factors related to the tech-
nique of FAF that may lead to a poor agreement with
GVF. Studies have shown that the sensitivity on perim-
etry may be linearly related to the ganglion cell density
in the local area of the retina being tested when both
are expressed in linear units [30]. However, hypo-
autofluorescence on FAF is related to loss of RPE ra-
ther than ganglion cells and thus may not have a linear
relationship with perimetric sensitivity, since the RPE
consists of non-neural components which are add-
itionally affected in BSCR.
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Another reason for the poor correlation between FAF
and GVF may be related to the natural history of BSCR.
Literature suggests that there may be a lack of corres-
pondence among various imaging tests in eyes with BSCR
[3, 17, 18]. This can be explained by the variable involve-
ment of structures such as the choroid, RPE, and the pho-
toreceptors by the disease process as the lesions of BSCR
evolve. If the retinochoroidal damage is detected early
using techniques such as FAF, it may be possible to halt
the progression of the disease with appropriate or esca-
lated systemic immunomodulatory therapy.
Limitations of this study include the retrospective na-
ture of analysis and small sample size. Due to the re-
quirement for fixation, the present study only included
patients with the ability to maintain fixation and may
not correlate well with patients who have advanced dis-
ease and can no longer fixate. The requirement for fix-
ation may also be a source of inclusion bias as patients
with higher grades of GVF loss were excluded from the
study. Approximately half the eyes were excluded from
the analysis due to ungradable image quality or poor pa-
tient cooperation/fixation. Such exclusion may represent a
source of bias and may affect the overall generalizability of
the results. An important aspect to consider is the scale of
measurement on GVF and FAF techniques. For example,
a loss of 3 dB on GVF represents 50 % loss of sensitivity,
since it is a logarithmic scale. On the other hand, FAF has
been considered as an all-or-none scale. The difference in
scale may represent a limitation in our ability to accurately
assess the structure-function relationship [29]. Moreover,
our study lacks a normal age-matched control group that
may help in determining the specificity of FAF grading
since this grading was categorical (normal or abnormal).
Additional, prospective studies, including a larger number
of patients, are warranted.
Conclusions
The results of this pilot study underscores the need to fol-
low patients with BSCR using multi-modal imaging as each
technique may contribute different information about the
disease status. It is relevant to combine structural and func-
tional testing to enhance our understanding of the disease
process and relationship between visual loss and underlying
tissue damage in diseases such as BSCR.
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